qunisol 5 ml dps
ochoa - ciprofloxacin,hydroxy propyl methylcellulose,benzalkonium chl. - dps - 0.3,0.25,0.02;% all w/v - 5 ml
unisol 100 mg/ml sol. for drinking water
vetpharma animal health s.l. - enrofloxacin 100 mg/ml - solution for use in drinking water - 100 mg/ml - enrofloxacin 100 mg/ml - enrofloxacin - poultry
unisolve formulation: each ml contains: sucrose .......... 20 mg sodium chloride...............5.69 mg disodium phosphate dehydr
msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - sterile phosphate buffered saline (vet.) - solution for freeze dried vaccine (im/sc) - formulation: each ml contains: sucrose .......... 20 mg sodium chloride...............5.69 mg disodium phosphate dehydrate .....
unisolve formulation: each ml contains: sucrose..................................20 mg sodium chloride.........................5.69 mg disodium phosphate dehydrate......1.28 mg potassium dihydrogen phosphate....520 mcg sterile water. .......... 1 ml solution for freeze-dried vaccine (im/sc)
msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - sterile phosphate buffered saline (vet.) - solution for freeze-dried vaccine (im/sc) - formulation: each ml contains: sucrose..................................20 mg sodium chloride.........................5.69 mg disodium phosphate dehydrate......1.28 mg potassium dihydrogen phosphate....520 mcg sterile water. .......... 1 ml
montelukast sodium- montelukast sodium tablet, coated
remedyrepack inc. - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - montelukast 10 mg - montelukast sodium tablets, chewable tablets and oral granules are indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. montelukast sodium tablets and chewable tablets are indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 6 years of age and older. montelukast sodium tablets, chewable tablets and oral granules are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. - hypersensitivity to any component of this product. risk summary available data from published prospective and retrospective cohort studies over decades with montelukast use in pregnant women have not established a drug-associated risk of major birth defects [see data] . in animal reproduction studies, no adverse developmental effects were observed with oral administration of montelukast to pregnant rats and rabbits during org
syntaris 0.025% nasal spray
teva uk ltd - flunisolide - spray - 25microgram/1dose
syntaris 0.025% nasal spray
dowelhurst ltd - flunisolide - spray - 25microgram/1dose
syntaris 0.025% nasal spray
sigma pharmaceuticals plc - flunisolide - spray - 25microgram/1dose
syntaris 0.025% nasal spray
waymade healthcare plc - flunisolide - spray - 25microgram/1dose
syntaris 0.025% nasal spray
lexon (uk) ltd - flunisolide - spray - 25microgram/1dose